Results 41 to 50 of about 4,196 (141)
EBioMedicine, 2023 Summary: Background: Vaccination reduces COVID-19-related hospitalization among older adults. However, how SARS-CoV-2 infection and vaccine regimens affect vaccine-elicited immunity remain unclear.
Carol Ho-Yan Fong +11 more
doaj +1 more source
Clinical and Translational Medicine, Volume 11, Issue 2, February 2021., 2021 Menstrual blood‐derived MSC transplantation significantly lowers the mortality of severe and critical SARS‐CoV‐2‐induced COVID‐19. This prospective and systematic report assessed the ability of menstrual blood‐derived MSCs to treat both severe and critically ill COVID‐19 patients.
Xiaowei Xu +28 more
wiley +1 more source
Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review
Journal of Infection and Public Health, 2021 Coronavirus disease-2019 (COVID-19), associated with the outbreak of deadly virus originating in Wuhan, China, is now a global health emergency and a matter of serious concern.
Madhusudan Goyal +4 more
doaj +1 more source
Brazilian Journal of Nephrology, 2023 Introduction: The immune response to different Coronavirus Disease 2019 (COVID-19) vaccines is under-investigated in end-stage kidney disease (ESKD) patients, especially in the Middle East and North Africa.
Ayman Abd El-Hameed +4 more
doaj +2 more sources
Vaccines, 2022 We quantitatively analyzed SARS-CoV-2 antibody levels in patients after two doses of the ChAdOx1 nCoV-19 vaccine and the third BNT162b2 booster. We obtained 255 serum samples from 149 healthcare workers 1 and 4 months after the third dose.
Nuri Lee +7 more
doaj +1 more source
Pfizer-BioNTech COVID-19 vaccine (also known as COMIRNATY) overview and safety
Updated Apr.
core +6 more sources
EBioMedicine, 2021 Background: The rapid vaccination campaign against COVID-19 in Israel relied on the BNT162b2 vaccine. We performed a longitudinal analysis of multiple cohorts, using individual data, to evaluate the effectiveness of the vaccine against new and ...
Aharona Glatman-Freedman +4 more
doaj +1 more source
, 2021 The objective of the systematic review is to assess the efficacy and safety of SARS-CoV-2 vaccines for individuals with haematological malignancies. We will limit inclusion to studies on the four vaccines currently authorized by the EMA and vaccines ...
Claire Iannizzi +10 more
core +1 more source
Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
Archives of Academic Emergency Medicine, 2022 Introduction: Knowledge of vaccine-related adverse events is crucial as they are among the most important factors that cause hesitation in receiving vaccines.
SeyedAhmad SeyedAlinaghi +13 more
doaj +1 more source
NGEU and Vaccines Strategy in the Wake of the COVID‐19 Pandemic: Outgrowing the Regulatory State
, 2022 JCMS: Journal of Common Market Studies, Volume 60, Issue S1, Page 101-113, September 2022.
Manuele Citi, Caroline de la Porte
wiley +1 more source